Adc Therapeutics Sa Stock In The News
| ADCT Stock | USD 4.68 0.04 0.85% |
The tone or emotional content of news articles related to ADC Therapeutics can affect its prices. Positive news sentiment can lead to an increase in demand for ADC Therapeutics' stock, while negative news sentiment can lead to a decrease in demand. Our overall analysis of ADC Therapeutics' news coverage and content from conventional and social sources shows investors' bearish mood towards ADC Therapeutics SA. The specific impact of ADC Therapeutics news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of ADC Therapeutics' overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using ADC Therapeutics headlines in addition to utilizing other, more conventional financial analysis modules. Check out ADC Therapeutics Backtesting and ADC Therapeutics Hype Analysis.
ADC |
ADC Therapeutics Today Top News and Investor Outlook
ADC Therapeutics SA Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide ADC and other traded companies coverage. We help investors stay connected with ADC headlines for the 23rd of April to make an informed investment decision based on correlating the impacts of news items on ADC Stock performance. Please note that trading solely based on the ADC Therapeutics SA hype is not for everyone as timely availability and quick action are needed to avoid losses.ADC Therapeutics stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the ADC earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about ADC Therapeutics that are available to investors today. That information is available publicly through ADC media outlets and privately through word of mouth or via ADC internal channels. However, regardless of the origin, that massive amount of ADC data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of ADC Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of ADC Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to ADC Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive ADC Therapeutics alpha.
ADC Largest EPS Surprises
Earnings surprises can significantly impact ADC Therapeutics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2023-05-09 | 2023-03-31 | -0.67 | -0.74 | -0.07 | 10 | ||
2021-08-03 | 2021-06-30 | -0.86 | -0.96 | -0.1 | 11 | ||
2023-08-08 | 2023-06-30 | -0.46 | -0.58 | -0.12 | 26 | ||
2020-06-03 | 2020-03-31 | -0.56 | -0.77 | -0.21 | 37 | ||
2022-11-08 | 2022-09-30 | -0.35 | -0.65 | -0.3 | 85 | ||
2022-03-03 | 2021-12-31 | -0.86 | -0.45 | 0.41 | 47 |
ADC Therapeutics Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to ADC Therapeutics Stock. Current markets are strongly bullish. About 76% of major world exchanges and indexes are currently up. See today's market update for more information.
18th of April 2024
HC Wainwright Comments on ADC Therapeutics SAs Q1 2024 Earnings - MarketBeat at news.google.com
4th of April 2024
ADC Therapeutics Announces Updates on LOTIS-7 Clinical Trial Evaluating ZYNLONTA in Combin... at finance.yahoo.com
3rd of April 2024
ADC Therapeutics ldt am Dienstag, den 9. April 2024 zu einer virtuellen Konferenz fr Forsc... at globenewswire.com
18th of March 2024
ADC Therapeutics Earns Outperform Rating from Royal Bank of Canada - MarketBeat at news.google.com
15th of March 2024
ADC Therapeutics SA Q4 2023 Earnings Call Transcript at insidermonkey.com
14th of March 2024
ADC Therapeutics Full Year 2023 Earnings Revenues Beat Expectations, EPS Lags at simplywall.st
13th of March 2024
ADC Therapeutics SA Reports Mixed 2023 Financial Results Amid Strategic Reset at gurufocus.com
27th of February 2024
ADC Therapeutics nimmt an der TD Cowen 44th Annual Health Care Conference teil at globenewswire.com
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards ADC Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, ADC Therapeutics' short interest history, or implied volatility extrapolated from ADC Therapeutics options trading.
Check out ADC Therapeutics Backtesting and ADC Therapeutics Hype Analysis. Note that the ADC Therapeutics information on this page should be used as a complementary analysis to other ADC Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Complementary Tools for ADC Stock analysis
When running ADC Therapeutics' price analysis, check to measure ADC Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ADC Therapeutics is operating at the current time. Most of ADC Therapeutics' value examination focuses on studying past and present price action to predict the probability of ADC Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ADC Therapeutics' price. Additionally, you may evaluate how the addition of ADC Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |
Is ADC Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ADC Therapeutics. If investors know ADC will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ADC Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.94) | Revenue Per Share 0.851 | Quarterly Revenue Growth (0.76) | Return On Assets (0.25) | Return On Equity (7.06) |
The market value of ADC Therapeutics is measured differently than its book value, which is the value of ADC that is recorded on the company's balance sheet. Investors also form their own opinion of ADC Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is ADC Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ADC Therapeutics' market value can be influenced by many factors that don't directly affect ADC Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ADC Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if ADC Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ADC Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.